Recruiting NCT07218380
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Why this may match: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms · Recruiting · United States, Australia +17 · Phase III
2 trials in this section
Detailed eligibility, including treatment history and laboratory results, still needs to be checked.
Why this may match: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms · Recruiting · United States, Australia +17 · Phase III
Why this may match: Prostate Cancer · Recruiting · China · Phase I / Phase II